衰弱筛查与衰弱路径降低衰弱老年创伤及急诊普通外科患者的住院时间、独立性丧失和30天再入院率
该质量改进项目为前后对照研究,纳入2016年10月至2017年10月单中心创伤及急诊普通外科(TEGS)连续收治的全部≥65岁患者,前3个月筛查衰弱获取基线结局,随后衰弱患者进入衰弱路径。239例筛查患者中70例(29.3%)为衰弱,所有患者均在入院24小时内完成筛查。路径实施后衰弱患者中位住院日从9天降至6天(p=0.4),30天再入院率从36.4%降至10.2%(p=0.04),独立性丧失从100%降至60%(降低40%,p=0.01);非衰弱患者结局无差异。作者结论认为该路径无需额外资源,但需更大队列和不同场景验证因果关系。
要点
- 所有≥65岁TEGS患者入院24小时内完成衰弱筛查,239例中70例(29.3%)为衰弱。
- 衰弱路径实施后衰弱患者30天再入院率从36.4%降至10.2%(p=0.04)。
- 衰弱患者独立性丧失从100%降至60%,降低40%(p=0.01)。
- 衰弱患者中位住院日从9天降至6天(p=0.4),未达统计学显著。
- 非衰弱老年TEGS患者结局在路径前后无差异,路径未对其造成负面影响。
适用人群与场景
- 单中心城市学术机构创伤及急诊普通外科(TEGS)收治的全部≥65岁老年患者,前瞻性队列,2016年10月至2017年10月。
诊断标准与关键阈值
- 衰弱状态通过衰弱筛查程序判定,具体筛查工具及界值原文未给出。
处置流程与药物剂量
- 第一步:所有≥65岁TEGS患者入院24小时内完成衰弱筛查。
- 第二步:筛查为衰弱的患者进入本中心衰弱路径(frailty pathway),非衰弱患者不进入该路径。
- 该路径不需要额外资源,而是将关注重点转向衰弱患者。
研究设计与关键结果
- 研究类型为前后对照的质量改进项目,前瞻性队列,单中心,纳入239例≥65岁TEGS患者,其中衰弱70例(29.3%)。
- 衰弱患者中位住院日从9天降至6天(p=0.4)。
- 衰弱患者30天再入院率从36.4%降至10.2%(p=0.04)。
- 衰弱患者独立性丧失从100%降至60%,降低40%(p=0.01)。
- 非衰弱老年患者结局在路径前后无差异。
证据类型、等级与局限
- 治疗性研究,证据等级IV级。
- 局限:原文作者指出需在更大队列和不同场景中实施该路径以确认干预与结局改善之间的因果关系。
对床旁实践的改变
- 作者认为对衰弱老年TEGS患者筛查衰弱并实施衰弱路径可降低住院时间、独立性丧失和30天再入院率,且无需额外资源、不影响非衰弱患者结局;需更大队列和不同场景验证因果关系。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Frail geriatric trauma and emergency general surgery (TEGS) patients have longer lengths of stay (LOS), more readmissions, and higher rates of postdischarge institutionalization than their nonfrail counterparts. Despite calls to action by national trauma coalitions, there are few published reports of prospective interventions. The objective of this quality improvement project was to first develop a frailty screening program, and, then, if frail, implement a novel frailty pathway to reduce LOS, 30-day readmissions, and loss of independence.
METHODS: This was a before-after study of a prospective cohort of all geriatric (≥65-years-old) patients admitted to the TEGS service from October 2016 to October 2017. All patients were screened for frailty for 3 months (preintervention) to obtain baseline outcomes. Subsequently, frail patients were entered into our frailty pathway (postintervention). Nonparametric statistical tests were used to assess significant differences in continuous variables; χ and Fisher exact tests were used for categorical variables, where appropriate. Both process and outcome measures were evaluated.
RESULTS: Of 239 geriatric TEGS patients screened, 70 (29.3%) were frail. All TEGS geriatric patients were screened within 24 hours of admission. Following frailty pathway implementation, median LOS for frail patients decreased from 9 to 6 days (p = 0.4), readmissions decreased from 36.4% to 10.2% (p = 0.04), and loss of independence decreased by 40%, (100% vs 60%; p = 0.01). Outcomes for nonfrail geriatric patients did not differ between cohorts.
CONCLUSIONS: Screening for frailty followed by implementing a frailty pathway decreased LOS, loss of independence, and 30-day readmission rates for frail geriatric TEGS patients at a single urban academic institution. The pathway required no additional resources; rather, we shifted focus toward frail patients without negatively affecting outcomes in nonfrail geriatric TEGS patients. Implementation of this pathway with larger patient cohorts and in varied settings is needed to confirm a causal relationship between our intervention and improved outcomes.
LEVEL OF EVIDENCE: Therapeutic study, level IV.
参考来源
- Engelhardt KE, Reuter Q, Liu J, et al. Frailty screening and a frailty pathway decrease length of stay, loss of independence, and 30-day readmission rates in frail geriatric trauma and emergency general surgery patients. J Trauma Acute Care Surg. 2018. PMID: 29659475. doi:10.1097/TA.0000000000001931
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。